Our study demonstrated that MAML1, an oncogene involved in HCC development, can interact with the transcription factor STAT3 and facilitate its acetylation, allowing it to easily access the promoter regions of regulatory genes and promoting HCC progression in vitro and in vivo. The gene discussed is STAT3; the disease is hepatocellular carcinoma.